Bill Aschenbach

Bill Aschenbach, PhD, MBA has extensive work experience in the pharmaceutical and biotech industry. Bill is currently the Executive Director and Head of Medical Affairs at Keros Therapeutics since May 2022. Prior to this, they were the Head of MS Life Cycle Management in Global Medical Affairs at Sanofi Genzyme from March 2018 to May 2022.

Before joining Sanofi Genzyme, Bill held the position of Vice President of Medical Affairs at Gelesis from July 2016 to November 2017. Bill also worked as the Scientific Director of U.S. Medical Affairs - Neurology & Immunology at EMD Serono, Inc. from August 2015 to June 2016 and as the Director of Medical Science Liaisons at the same company from December 2014 to August 2015.

Bill's previous roles also include Director of Global Medical Research at Biogen Idec from August 2011 to December 2014, Senior Manager of Medical Communications at the same company from September 2008 to January 2011, and Medical Science Liaison at PDL BioPharma from November 2006 to April 2008.

Bill began their career as a Regional Scientific Manager at AstraZeneca Pharmaceuticals in July 2005 and served as a Senior Scientist at CombinatoRx from 2003 to 2005.

In addition to their work experience, Bill holds a PhD and MBA, demonstrating their commitment to advancing their education in the field.

Bill Aschenbach, PhD, MBA, has an extensive education history. Bill began their academic journey at Virginia Tech, where they pursued a Bachelor of Science (B.S.) and a Master of Science (M.S.) in Exercise Physiology from 1988 to 1995. Later on, they attended Auburn University, from 1995 to 2000, where they earned their Doctor of Philosophy (Ph.D.) in Exercise Physiology.

After completing their Ph.D., Aschenbach went on to Harvard Medical School, where they worked as a Post-Doctoral Fellow from 1999 to 2003. During this period, they specialized in the field of Medicine and Metabolism.

To further expand their knowledge and skills, Aschenbach pursued another degree at Boston College Carroll School of Management. From 2008 to 2012, they successfully obtained a Master of Business Administration (M.B.A.) with a focus on Business Administration.

Overall, Aschenbach's educational trajectory reflects their dedication and commitment to both the scientific and business aspects of their field.